Skip to content

AMYLIN PHARMACEUTICALS INC

Delisted

CIK 881464fmd_0M28KBES2B5H3CXHZTCGXGS5K3Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2008 to Jun 30, 2012, 14 periods

Income Statement · Annual · Millions · USD
Line itemFY2008FY2009FY2010FY2011
Total revenues770758669651
Cost of revenue92836248
Gross profit678675607602
Research and development223198183161
Selling, general and administrative395330277271
Operating income(297)(173)(127)(491)
Interest and investment income–832
Other non-operating income (expense)–(13)(26)(52)
Net income(322)(186)(152)(543)